Loading...
Agilon Health, Inc.
AGL•NYSE
Healthcare
Medical - Care Facilities
$1.99
$-0.07(-3.40%)
Agilon Health, Inc. (AGL) Financial Performance & Income Statement Overview
Review Agilon Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
40.41%
↑ 40.41%
Operating Income Growth
-25.85%
↓ 25.85%
Net Income Growth
0.95%
↑ 0.95%
Operating Cash Flow Growth
63.01%
↑ 63.01%
Operating Margin
-5.11%
↓ 5.11%
Gross Margin
-0.53%
↓ 0.53%
Net Profit Margin
-4.04%
↓ 4.04%
ROE
-43.55%
↓ 43.55%
ROIC
-54.86%
↓ 54.86%
Agilon Health, Inc. (AGL) Income Statement & Financial Overview
Review Agilon Health, Inc.'s (AGL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $1.52B | $1.45B | $1.48B | $1.60B |
| Cost of Revenue | $1.56B | $1.52B | $1.46B | $1.54B |
| Gross Profit | -$38.26M | -$64.17M | $26.27M | $69.24M |
| Gross Profit Ratio | -$0.03 | -$0.04 | $0.02 | $0.04 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $59.76M | $63.12M | $68.74M | $74.007M |
| Operating Expenses | $69.84M | $69.34M | $68.74M | $74.007M |
| Total Costs & Expenses | $1.63B | $1.58B | $1.53B | $1.61B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $1.57M | $1.62M | $1.70M | $1.28M |
| Depreciation & Amortization | $6.49M | $6.22M | $5.91M | $5.84M |
| EBITDA | -$96.61M | -$112.43M | -$22.64M | $1.08M |
| EBITDA Ratio | -$0.06 | -$0.08 | -$0.02 | $0.001 |
| Operating Income | -$108.10M | -$133.51M | -$42.48M | -$4.76M |
| Operating Income Ratio | -$0.07 | -$0.09 | -$0.03 | -$0.003 |
| Other Income/Expenses (Net) | $3.43M | $16.49M | $13.10M | $10.29M |
| Income Before Tax | -$104.67M | -$117.02M | -$30.25M | $3.11M |
| Income Before Tax Ratio | -$0.07 | -$0.08 | -$0.02 | $0.002 |
| Income Tax Expense | $1.76M | -$590000.00 | $417000.00 | -$133000.00 |
| Net Income | -$105.79M | -$117.61M | -$30.68M | $2.70M |
| Net Income Ratio | -$0.07 | -$0.08 | -$0.02 | $0.002 |
| EPS | -$0.26 | -$0.29 | -$0.07 | $0.007 |
| Diluted EPS | -$0.26 | -$0.29 | -$0.07 | $0.007 |
| Weighted Avg Shares Outstanding | $412.04M | $411.59M | $411.27M | $408.94M |
| Weighted Avg Shares Outstanding (Diluted) | $412.04M | $411.59M | $411.27M | $408.94M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan